MedTrace Logo

Patient Outcomes Using HIP7 Software as Compared to Conventional THA

NCT04989998 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-07-29

No results posted yet for this study

Summary

The study is designed to demonstrate how Hip7 software can lead to improved patient outcomes compared to conventional procedures with standard instrumentation for total hip arthroplasties (THA) surgery.

Conditions

  • Hip Replacement

Interventions

DEVICE

Hip7 Software on Kick/ CORI platforms

Total hip arthroplasty surgery using Hip7 software on Kick or CORI platforms using R3 Polarstem implants.

DEVICE

Conventional surgical procedures

THA surgery using standard, manual instrumentation and digital templating techniques using R3 polarstem implants.

Sponsors & Collaborators

  • Smith & Nephew Orthopaedics AG

    lead INDUSTRY

Principal Investigators

  • Edward T Davis, MB ChB, M.Sc, PGCME, FRCS(T&O) · The Royal Orthopaedic Hospital NHS Foundation Trust

  • Yixin Zhou · Beijing Jishuitan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2024-10-31
Completion
2024-10-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04989998 on ClinicalTrials.gov